Antithetical NFATc1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticityShiv K. Singh, Volker Ellenrieder, Nai‐Ming Chen et al.|The EMBO Journal|2015Cited by 96
Maintenance therapy with 5-fluoruracil/leucovorin (5FU/LV) plus panitumumab (pmab) or 5FU/LV alone in RAS wildtype (WT) metastatic colorectal cancer (mCRC) - the PANAMA trial (AIO KRK 0212).Dominik Paul Modest, Tanja Trarbach, Lothar Müller et al.|Journal of Clinical Oncology|2021Cited by 6